CA2688486A1 - Formulations de sesquiterpene, trousses et procedes d'utilisation associes - Google Patents
Formulations de sesquiterpene, trousses et procedes d'utilisation associes Download PDFInfo
- Publication number
- CA2688486A1 CA2688486A1 CA002688486A CA2688486A CA2688486A1 CA 2688486 A1 CA2688486 A1 CA 2688486A1 CA 002688486 A CA002688486 A CA 002688486A CA 2688486 A CA2688486 A CA 2688486A CA 2688486 A1 CA2688486 A1 CA 2688486A1
- Authority
- CA
- Canada
- Prior art keywords
- pharmaceutical composition
- caryophyllene
- beta
- group
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002688486A CA2688486A1 (fr) | 2007-05-31 | 2008-06-02 | Formulations de sesquiterpene, trousses et procedes d'utilisation associes |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94111707P | 2007-05-31 | 2007-05-31 | |
US60/941,117 | 2007-05-31 | ||
PCT/CA2008/000865 WO2008144880A1 (fr) | 2007-05-31 | 2008-05-06 | Compositions servant à prévenir ou à traiter le syndrome d'anorexie-cachexie et leurs procédés d'utilisation |
CAPCT/CA2008/000865 | 2008-05-06 | ||
PCT/CA2008/001063 WO2008144942A1 (fr) | 2007-05-31 | 2008-06-02 | Formulations de sesquiterpène, trousses et procédés d'utilisation associés |
CA002688486A CA2688486A1 (fr) | 2007-05-31 | 2008-06-02 | Formulations de sesquiterpene, trousses et procedes d'utilisation associes |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2688486A1 true CA2688486A1 (fr) | 2008-12-04 |
Family
ID=41571027
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002688486A Abandoned CA2688486A1 (fr) | 2007-05-31 | 2008-06-02 | Formulations de sesquiterpene, trousses et procedes d'utilisation associes |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2688486A1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT201800004027A1 (it) * | 2018-03-28 | 2019-09-28 | Jointherapeutics S R L | Composizione per il trattamento di patologie infiammatorie |
CN114377067A (zh) * | 2020-10-22 | 2022-04-22 | 中国科学院上海营养与健康研究所 | 葡萄籽提取物在制备靶向清除肿瘤微环境衰老细胞及抑制肿瘤的药物中的用途 |
-
2008
- 2008-06-02 CA CA002688486A patent/CA2688486A1/fr not_active Abandoned
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT201800004027A1 (it) * | 2018-03-28 | 2019-09-28 | Jointherapeutics S R L | Composizione per il trattamento di patologie infiammatorie |
WO2019186355A1 (fr) * | 2018-03-28 | 2019-10-03 | Jointherapeutics Srl | Composition pour le traitement de maladies inflammatoires |
CN114377067A (zh) * | 2020-10-22 | 2022-04-22 | 中国科学院上海营养与健康研究所 | 葡萄籽提取物在制备靶向清除肿瘤微环境衰老细胞及抑制肿瘤的药物中的用途 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20110008465A1 (en) | Sesquiterpene formulations, kits and methods of use thereof | |
Shi et al. | Co-delivery of docetaxel and chloroquine via PEO–PPO–PCL/TPGS micelles for overcoming multidrug resistance | |
Li et al. | Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways | |
Nakase et al. | Transferrin receptor-dependent cytotoxicity of artemisinin–transferrin conjugates on prostate cancer cells and induction of apoptosis | |
Wang et al. | Lethal quercetin-digoxin interaction in pigs | |
US11963942B2 (en) | Oral taxane compositions and methods | |
Cortes et al. | Eribulin mesylate, a novel microtubule inhibitor in the treatment of breast cancer | |
MX2014001586A (es) | Formulaciones de cabazitaxel y metodos para preparar las mismas. | |
WO2012031293A1 (fr) | Compositions et méthodes utilisables en vue du traitement du cancer | |
WO2015172712A1 (fr) | Composition pharmaceutique pour injection avec effet synergique de la vitamine c et des médicaments antitumoraux | |
US11439586B2 (en) | Intratumour injection formulation | |
PT1189637E (pt) | Composições para melhorar a biodisponibilidade de fármacos administrados oralmente | |
Sartaj et al. | Exploring the therapeutic potential of nanostructured lipid carrier approaches to tackling the inherent lacuna of chemotherapeutics and herbal drugs against breast cancer | |
Ho et al. | Enhanced oral bioavailability of paclitaxel by d-α-tocopheryl polyethylene glycol 400 succinate in mice | |
CA2688486A1 (fr) | Formulations de sesquiterpene, trousses et procedes d'utilisation associes | |
EP2632264B1 (fr) | Nouvelles formulations de composés chimiques hydro-insolubles et procédés d'utilisation d'une formulation de composé fl118 pour thérapie cancéreuse | |
Hao et al. | Novel fluorinated docetaxel analog for anti-hepatoma: Molecular docking and biological evaluation | |
CN111773388A (zh) | A-失碳-5α雄甾烷化合物类药物与抗癌药物的联合应用 | |
CA2530311A1 (fr) | Traitement du cancer au moyen d'epothilones | |
Calleja | New chemotherapy approaches based on mucus-penetrating nanoparticles as carriers for paclitaxel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |